Search Results - "Trollet, C."

PABPN1 gene therapy for oculopharyngeal muscular dystrophy by Malerba, A., Klein, P., Bachtarzi, H., Jarmin, S. A., Cordova, G., Ferry, A., Strings, V., Espinoza, M. Polay, Mamchaoui, K., Blumen, S. C., St Guily, J. Lacau, Mouly, V., Graham, M., Butler-Browne, G., Suhy, D. A., Trollet, C., Dickson, G.

“…Oculopharyngeal muscular dystrophy (OPMD) is an autosomal dominant, late-onset muscle disorder characterized by ptosis, swallowing difficulties, proximal limb…”
Get full text

Electrotransfer into skeletal muscle for protein expression by Trollet, C, Bloquel, C, Scherman, D, Bigey, P

“…An efficient and safe method to deliver DNA in vivo is a requirement for several purposes, such as study of gene function and gene therapy applications. Among…”
Get more information

Generation of High-Titer Neutralizing Antibodies against Botulinum Toxins A, B, and E by DNA Electrotransfer by TROLLET, C, PEREIRA, Y, BURGAIN, A, LITZLER, E, MEZRAHI, M, SEGUIN, J, MANICH, M, POPOFF, M. R, SCHERMAN, D, BIGEY, P

“…Classifications Services IAI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
Get full text

Gene replacement therapy as a novel approach for the treatment of oculopharyngeal muscular dystrophy by Malerba, A, Klein, P, Bachtarzi, H, Jarmin, S, Ferry, A, Graham, M, Strings, V, Butler-Browne, G, Suhy, D, Dickson, G, Trollet, C

Get full text

P9 Adeno-associated virus (AAV)-mediated RNA interference to PABPN1 combined with an optimised resistant transgene for rescue of the muscle specific disease oculopharyngeal muscular dystrophy (OPMD) by Bachtarzi, H, Malerba, A, Jarmin, S, Trollet, C, Graham, M, Dickson, J.G

Get full text

G.O.5 by Trollet, C, Chartier, A, Klein, P, Barbezier, N, Gidaro, T, Casas, F, Carberry, S, Dowling, P, Maynadier, L, Dickson, G, Mouly, V, Ohlendieck, K, Butler-Browne, G, Simonelig, M

“…Oculopharyngeal muscular dystrophy (OPMD) is an autosomal dominant inherited, slow progressing, late onset degenerative muscular disorder where a small group…”
Get full text

O01 Autologous cell therapy in oculopharyngeal muscular dystrophy (OPMD) by Périé, S, Trollet, C, Mouly, V, Larghero, J, Mamchaoui, K, Bouazza, B, Toy-Miou, M, Marolleau, J.P, Eymard, B, Laforêt, P, Chapon, F, Butler-Browne, G, Guily, J. Lacau St

Get full text

P.16.12 OPMD from the myoblast’s and fibroblast’s point of view by Gidaro, T, Negroni, E, Klein, P, Oloko, M, Lesnik, M, Bigot, A, Mamchaoui, K, Périé, S, Guily, J.L. St, Butler-Browne, G, Mouly, V, Trollet, C

“…Oculopharyngeal muscular dystrophy (OPMD) is a late onset autosomal dominant inherited dystrophy due to an expansion of GCG repeats in the coding region of the…”
Get full text

G.P.106 Immunohistochemical study of cricopharyngeal muscle in oculopharyngeal muscular dystrophy by Gidaro, T, Perié, S, Lesnik, M, Negroni, E, Oloko, M, st Guily, J. Lacau, Butler-Browne, G, Mouly, V, Trollet, C

“…Abstract Several studies have reported abnormalities in muscle histology of cricopharyngeal muscle (CPM) from healthy donors. However, very little is known…”
Get full text

P2.45 Proteomic studies of muscle progenitor cells in affected and non-affected oculopharyngeal muscular dystrophy muscles by Gidaro, T, Mamchaoui, K, Bouazza, B, Perié, S, Svinartchouk, F, Blumen, S, Guily, J.J.S, Butler-Browne, G, Mouly, V, Trollet, C

Get full text

D.P.4.11 Expression and siRNA targeting of PABPN1 as a model for oculopharyngeal muscular dystrophy (OPMD) by Trollet, C, Benstead, J, Graham, I, Yáñez, R, Antoniou, M, Dickson, G

Get full text

G.P.8.08 Codon optimisation of microdystrophin results in improvements in expression and physiological outcome in the mdx mouse following AAV8 gene transfer by Foster, H, Wells, D.J, Trollet, C, Athanasopoulos, T, Graham, I, Foster, K, Dickson, J.G

Get full text

Optical imaging of luminescence for in vivo quantification of gene electrotransfer in mouse muscle and knee by Bloquel, C, Trollet, C, Pradines, E, Seguin, J, Scherman, D, Bureau, M F

“…Optical imaging is an attractive non-invasive way to evaluate the expression of a transferred DNA, mainly thanks to its lower cost and ease of realization. In…”
Get full text

G.P.8.09 Evaluating the potential of AAV8 mediated intravenous transfer of myostatin propeptide to ameliorate the muscle pathology in mdx mouse by Foster, K, Graham, I, Foster, H, Trollet, C, Yaworsky, P, Walsh, F, Sharp, P, Wells, D, Dickson, G

Get full text

T.P.1.09 Oculopharyngeal muscular dystrophy (OPMD): Physiopathological mechanisms and gene therapy approaches by Trollet, C, Bales, O, Anvar, Y, Foster, K, Mamchaoui, K, t Hoen, P.A, Raz, V, van der Maarel, S, Antoniou, M, Mouly, V, Butler-Browne, G, Dickson, G

Get full text

P176 Immortalized human muscle cells: easy-to-use models to study neuromuscular diseases by Butler-Browne, G., Ohana, J., Mamchaoui, K., Bensalah, M., Negroni, E., Trollet, C., Bigot, A., Mouly, V.

“…In recent years, therapeutic approaches for neuromuscular diseases have been developed and new strategies are currently emerging. Human cellular models adapted…”
Get full text

594P FUS/TLS as a potential regulator of PABPN1 in skeletal muscle? by Mouigni, H., Altin, N., Ohana, J., Kondili, M., Dhiab, J., Muraine, L., Lemaitre, M., Meunier, P., Butler-Browne, G., Mouly, V., Bigot, A., Negroni, E., Trollet, C.

“…Poly(A) binding protein nuclear 1 (PABPN1) is an ubiquitous polyadenylation factor that activates the poly(A) polymerase (PAP), controls poly(A) tail length of…”
Get full text

268P Age and sex affect human skeletal muscle secretome by Crisol, B., Pinzon, N., Orio, J., Gaut-Serey, L., Ohana, J., Bensalah, M., Peterson, C., Butler-Browne, G., Mouly, V., Bigot, A., Trollet, C.

“…Aging is a gradual decline in physiological well-being, resulting in diminished tissue functionality. During aging, skeletal muscle strength and mass decrease…”
Get full text

Saving dopaminergic neurons from endoplasmic reticulum (ER) stress - A breakthrough approach to fight Parkinson's disease by Gentile, L., Nasir, A., Sinane, M., Conan, P., Ückert, A.-K., Leist, M., Friocourt, G., Trollet, C., Bihel, F., Voisset, C.

Get full text

P166 Deciphering the genetic cause of oculopharyngodistal myopathy in a French cohort using Cas9-targeted long-read sequencing by Benarroch, L., Nelson, I., Stojkovic, T., Oumoussa, B Mohand, Madry, H., Boelle, P., Labreche, K., Tomé, S., Trollet, C., Bonne, G.

“…Oculopharyngodistal myopathy (OPDM) is a rare neuromuscular disorder characterized by progressive ptosis, ophtalmoplegia, dysphagia and facial and distal limb…”
Get full text